CAS: 55496-55-4; Methyl[2-(Pyridin-4-yl)Ethyl]Amine

该化合物是一种有机化合物,其特点是其环结构被氨基乙基组和甲基组所替代,在室温下,它是一种无色的黄色淡液,呈现出强烈的气味,在水和有机溶剂中溶解,由于氨基胺有能力形成氢结体,这种化合物在水中和有机剂中很常见.N-M乙基-4-丙烯胺以其基本性而著称,其特性可归因于有矿功能组的存在,允许其在各种化学反应中作为核分裂体发挥作用,还可参与氢的结合,影响其再活性和与其他物质的相互作用,这种复合体被用于各种用途,包括作为有机合成的建筑块以及生产药品和农用化学品.在处理该化合物时,应当注意安全防范,因为它可能会引起皮肤,眼睛和呼吸系统.

结构式图片

相似化合物

13258-63-4 101252-40-8 15430-49-6

欧盟法规

C&L通报

上下游产品

CAS号54401-85-3 4-吡啶乙酸乙酯 | CAS号100-43-6 4-乙烯基吡啶 | CAS号74-89-5 氨基甲烷

合成工艺路线路线简述

    📜4-吡啶乙酸乙酯置于盐酸,Sodium Hydroxide体系中,用 甲醇,甲苯 作为反应溶剂,化学反应生成 N-甲基-2-(吡啶-4-基)乙胺
    参考文献:Tachykinin Antagonists
    标题:Tachykinin Antagonists
    摘要:式(I)的化合物,其中q.Sup.1代表芳基;虚线代表可选的共价键;x和y中的一个代表h,另一个代表羟基或c.Sub.1-6烷氧基,或者x和y在一起形成.Dbd.O或.Dbd.Nor.Sup.5的基团,其中r.Sup.5为h或c.Sub.1-6烷基;z代表o,S或nr.Sup.2,其中r.Sup.2为h或c.Sub.1-6烷基;w代表1,2,3,4,5或6个碳原子的饱和或不饱和碳氢链或键;r.Sup.1代表h或c.Sub.1-6烷基.r.Sup.3代表h,C.Sub.1-6烷基或c.Sub.2-6烯基;r.Sup.4代表可选择取代的苯基;r.Sup.6代表指定的氨基或可选择取代的芳香或非芳香氮杂环或氮杂双环基团;盐和前药是缩短素受体拮抗剂.

    海关参考信息

    专利信息


    专利号:US-2023151034-A1
    优先权日:2020-03-17
    标题:Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
    发明人:JACOBSON IRINA C; LEE SAM SK; PIZARRO NOVOA JUAN CARLOS
    权利人:COCRYSTAL PHARMA INC
    摘要:Peptidomimetic N5-methyl-N2-(nonanoyl-L-leucyl)-L-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds for use in methods of inhibiting the replication of noroviruses and coronaviruses in a biological sample or patient, for use in reducing the amount of noroviruses or coronaviruses in a biological sample or patient, and for use in treating norovirus and coronavirus in a patient, comprising administering to said biological sample or patient a safe and effective amount of a compound represented by formulae I or II, or a pharmaceutically acceptable salt thereof. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. page 99 to page 271; examples 1 to 3; compounds A1 to A104 and B1 to B66; tables A to E).

    专利号:US-2008194629-A1
    优先权日:2005-05-03
    标题 :3-Mono-and 3,5-Disubstituted Piperidine Derivatives as Renin Inhibitors
    发明人:BAESCHLIN DANIEL KASPAR; BREITENSTEIN WERNER; EHRHARDT CLAUS; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; ZIMMERMANN JUERG; RUDISSER SIMON; VANGREVELINGHE ERIC; IRIE OSAMU; UMEMURA ICHIRO; SUZUKI MASAKI; MOGI MUNETO; KANAZAWA TAKANORI; YOKOKAWA FUMIAKI; NIHONYANAGI ATSUKO
    权利人:BAESCHLIN DANIEL KASPAR; BREITENSTEIN WERNER; EHRHARDT CLAUS; MAIBAUM JUERGEN KLAUS; OSTERMANN NILS; ZIMMERMANN JUERG; RUDISSER SIMON; VANGREVELINGHE ERIC; IRIE OSAMU; UMEMURA ICHIRO; SUZUKI MASAKI; MOGI MUNETO; KANAZAWA TAKANORI; YOKOKAWA FUMIAKI; NIHONYANAGI ATSUKO
    摘要:The invention relates to 3,5-piperidine compounds, these compounds for use in the diagnostic and therapeutic treatment of a warm-blooded animal, especially for the treatment of a disease (=disorder) that depends on activity of renin; the use of a compound of that class for the preparation of a pharmaceutical formulation for the treatment of a disease that depends on activity of renin; the use of a compound of that class in the treatment of a disease that depends on activity of renin; pharmaceutical formulations comprising a 3,5-piperidine compound, and/or a method of treatment comprising administering a 3,5-piperidine compound, a method for the manufacture of a 3,5-piperidine compound, and novel intermediates and partial steps for their synthesis. Especially, the 3,5-piperidine compounds have the formula I, wherein the symbols have the meanings described in the specification.

    专利号:US-6613942-B1
    优先权日:1997-07-01
    标题 :Glucagon antagonists/inverse agonists
    发明人:LING ANTHONY; GREGOR VLAD; GONZALEZ JAVIER; HONG YUFENG; KIEL DAN; KUKI ATSUO; SHI SHENGHUA; NAERUM LARS; MADSEN PETER; SAMS CHRISTIAN; LAU JESPER; PLEWE MICHAEL BRUNO; FENG JUN; TENG MIN; JOHNSON MICHAEL DAVID; TESTON KIMBERLY ANN; SIDELMANN ULLA GROVE; KNUDSEN LOTTE BJERRE
    权利人:NOVO NORDISK AS
    摘要:Non-peptide compounds comprising a central hydrazide motif and methods for the synthesis thereof are disclosed. The compounds act to antagonize the action of the glucagon peptide hormone.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1016/j.antiviral.2011.06.006
    摘要:Campagnola G, Gong P, Peersen OB. High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. Antiviral Research. 2011 Sep;91(3):241–51. doi: 10.1016/j.antiviral.2011.06.006.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知